Australia’s peak body for dentists is pushing for a publicly funded, dental health program for older Australians and has ...

Researchers explore the impact of exercise on the short-term regulation of insulin pathways in brain circuits.

Retatrutide targets GIP and GLP-1 – the same as Lilly’s fast-growing diabetes ... ADA, Pfizer revealed that it had decided to end the development of one of its once-daily oral GLP-1 agonist ...

This information helps your health care provider tailor a treatment plan that’s ... including those conducted by the American Diabetes Association (ADA), the Centers for Disease Control and ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...

BofA Securities maintained a Buy rating on Eli Lilly stock (NYSE:LLY), with a price target set at $997.00. With a market capitalization of $706 billion and impressive revenue growth of 27.4% over the ...

As such, the American Diabetes Association (ADA) recognizes CGM as an integral component of effective treatment planning for many patients with diabetes taking insulin. CGMs can also be used with ...

Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

The main goal of diabetes treatment is to keep your blood sugar levels in target range. To help monitor them, your doctor will order blood work on a regular basis, including an A1C test.